Illumina Body Map 2: averaged replicates
Gene Symbol | Gene ID | Gene Info |
---|---|---|
MECP2
|
ENSG00000169057.15 | methyl-CpG binding protein 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MECP2 | hg19_v2_chrX_-_153363188_153363212 | -0.14 | 4.6e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_-_2050852 | 4.20 |
ENST00000541165.1
ENST00000591601.1 |
MKNK2
|
MAP kinase interacting serine/threonine kinase 2 |
chr7_-_139477500 | 3.97 |
ENST00000406875.3
ENST00000428878.2 |
HIPK2
|
homeodomain interacting protein kinase 2 |
chr10_+_6186847 | 3.64 |
ENST00000536985.1
ENST00000379789.4 |
PFKFB3
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
chr19_+_35521616 | 3.24 |
ENST00000595652.1
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
chr20_+_48807351 | 3.22 |
ENST00000303004.3
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta |
chr9_+_137218362 | 3.14 |
ENST00000481739.1
|
RXRA
|
retinoid X receptor, alpha |
chr19_-_33793430 | 3.02 |
ENST00000498907.2
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha |
chr9_-_134615326 | 2.97 |
ENST00000438647.1
|
RAPGEF1
|
Rap guanine nucleotide exchange factor (GEF) 1 |
chr16_+_21610879 | 2.91 |
ENST00000396014.4
|
METTL9
|
methyltransferase like 9 |
chr20_+_57466461 | 2.82 |
ENST00000306090.10
|
GNAS
|
GNAS complex locus |
chr12_+_58148842 | 2.82 |
ENST00000266643.5
|
MARCH9
|
membrane-associated ring finger (C3HC4) 9 |
chr14_-_24664776 | 2.76 |
ENST00000530468.1
ENST00000528010.1 ENST00000396854.4 ENST00000524835.1 ENST00000261789.4 ENST00000525592.1 |
TM9SF1
|
transmembrane 9 superfamily member 1 |
chr16_+_85646763 | 2.75 |
ENST00000411612.1
ENST00000253458.7 |
GSE1
|
Gse1 coiled-coil protein |
chr12_-_54982300 | 2.75 |
ENST00000547431.1
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
chr17_-_66287310 | 2.71 |
ENST00000582867.1
|
SLC16A6
|
solute carrier family 16, member 6 |
chr19_+_35521572 | 2.70 |
ENST00000262631.5
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
chr14_-_24664540 | 2.64 |
ENST00000530563.1
ENST00000528895.1 ENST00000528669.1 ENST00000532632.1 |
TM9SF1
|
transmembrane 9 superfamily member 1 |
chr6_-_32157947 | 2.61 |
ENST00000375050.4
|
PBX2
|
pre-B-cell leukemia homeobox 2 |
chr16_+_29817841 | 2.58 |
ENST00000322945.6
ENST00000562337.1 ENST00000566906.2 ENST00000563402.1 ENST00000219782.6 |
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
chr22_+_46546494 | 2.56 |
ENST00000396000.2
ENST00000262735.5 ENST00000420804.1 |
PPARA
|
peroxisome proliferator-activated receptor alpha |
chr16_+_85646891 | 2.51 |
ENST00000393243.1
|
GSE1
|
Gse1 coiled-coil protein |
chr2_-_127864577 | 2.49 |
ENST00000376113.2
|
BIN1
|
bridging integrator 1 |
chrX_+_109245863 | 2.47 |
ENST00000372072.3
|
TMEM164
|
transmembrane protein 164 |
chr2_-_178129551 | 2.43 |
ENST00000430047.1
|
NFE2L2
|
nuclear factor, erythroid 2-like 2 |
chr2_-_127864839 | 2.41 |
ENST00000409400.1
ENST00000357970.3 ENST00000393040.3 ENST00000348750.4 ENST00000259238.4 ENST00000346226.3 ENST00000393041.3 ENST00000351659.3 ENST00000352848.3 ENST00000316724.5 |
BIN1
|
bridging integrator 1 |
chr16_+_3096638 | 2.40 |
ENST00000336577.4
|
MMP25
|
matrix metallopeptidase 25 |
chr12_-_76478446 | 2.38 |
ENST00000393263.3
ENST00000548044.1 ENST00000547704.1 ENST00000431879.3 ENST00000549596.1 ENST00000550934.1 ENST00000551600.1 ENST00000547479.1 ENST00000547773.1 ENST00000544816.1 ENST00000542344.1 ENST00000548273.1 |
NAP1L1
|
nucleosome assembly protein 1-like 1 |
chr19_-_913160 | 2.36 |
ENST00000361574.5
ENST00000587975.1 |
R3HDM4
|
R3H domain containing 4 |
chr17_-_66287350 | 2.36 |
ENST00000580666.1
ENST00000583477.1 |
SLC16A6
|
solute carrier family 16, member 6 |
chr8_-_141645645 | 2.34 |
ENST00000519980.1
ENST00000220592.5 |
AGO2
|
argonaute RISC catalytic component 2 |
chr12_-_76478386 | 2.31 |
ENST00000535020.2
|
NAP1L1
|
nucleosome assembly protein 1-like 1 |
chr2_-_235405679 | 2.30 |
ENST00000390645.2
|
ARL4C
|
ADP-ribosylation factor-like 4C |
chr8_-_134584092 | 2.28 |
ENST00000522652.1
|
ST3GAL1
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
chr10_+_31608054 | 2.27 |
ENST00000320985.10
ENST00000361642.5 ENST00000560721.2 ENST00000558440.1 ENST00000424869.1 ENST00000542815.3 |
ZEB1
|
zinc finger E-box binding homeobox 1 |
chr17_-_4890649 | 2.26 |
ENST00000361571.5
|
CAMTA2
|
calmodulin binding transcription activator 2 |
chrX_-_153714994 | 2.25 |
ENST00000369660.4
|
UBL4A
|
ubiquitin-like 4A |
chr5_+_149865377 | 2.25 |
ENST00000522491.1
|
NDST1
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
chr19_+_35521699 | 2.24 |
ENST00000415950.3
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
chr11_-_1780261 | 2.23 |
ENST00000427721.1
|
RP11-295K3.1
|
RP11-295K3.1 |
chr1_+_90286562 | 2.21 |
ENST00000525774.1
ENST00000337338.5 |
LRRC8D
|
leucine rich repeat containing 8 family, member D |
chr7_-_105925367 | 2.20 |
ENST00000354289.4
|
NAMPT
|
nicotinamide phosphoribosyltransferase |
chr19_+_1286097 | 2.18 |
ENST00000215368.2
|
EFNA2
|
ephrin-A2 |
chr11_+_117049854 | 2.18 |
ENST00000278951.7
|
SIDT2
|
SID1 transmembrane family, member 2 |
chr21_-_36262032 | 2.17 |
ENST00000325074.5
ENST00000399237.2 |
RUNX1
|
runt-related transcription factor 1 |
chr20_-_60718430 | 2.16 |
ENST00000370873.4
ENST00000370858.3 |
PSMA7
|
proteasome (prosome, macropain) subunit, alpha type, 7 |
chr9_-_134615443 | 2.16 |
ENST00000372195.1
|
RAPGEF1
|
Rap guanine nucleotide exchange factor (GEF) 1 |
chr15_-_102029873 | 2.15 |
ENST00000348070.1
ENST00000358417.3 ENST00000344273.2 |
PCSK6
|
proprotein convertase subtilisin/kexin type 6 |
chr2_+_238600788 | 2.15 |
ENST00000289175.6
ENST00000244815.5 |
LRRFIP1
|
leucine rich repeat (in FLII) interacting protein 1 |
chr6_-_166796461 | 2.12 |
ENST00000360961.6
ENST00000341756.6 |
MPC1
|
mitochondrial pyruvate carrier 1 |
chr1_+_206680879 | 2.11 |
ENST00000355294.4
ENST00000367117.3 |
RASSF5
|
Ras association (RalGDS/AF-6) domain family member 5 |
chr22_-_47134077 | 2.11 |
ENST00000541677.1
ENST00000216264.8 |
CERK
|
ceramide kinase |
chr4_+_38665810 | 2.10 |
ENST00000261438.5
ENST00000514033.1 |
KLF3
|
Kruppel-like factor 3 (basic) |
chr9_-_139581848 | 2.10 |
ENST00000538402.1
ENST00000371694.3 |
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 |
chr1_+_27153173 | 2.10 |
ENST00000374142.4
|
ZDHHC18
|
zinc finger, DHHC-type containing 18 |
chr17_+_21188012 | 2.09 |
ENST00000529517.1
|
MAP2K3
|
mitogen-activated protein kinase kinase 3 |
chr14_+_75894714 | 2.09 |
ENST00000559060.1
|
JDP2
|
Jun dimerization protein 2 |
chr13_+_113863858 | 2.08 |
ENST00000375440.4
|
CUL4A
|
cullin 4A |
chr19_+_1249869 | 2.07 |
ENST00000591446.2
|
MIDN
|
midnolin |
chr1_-_33815486 | 2.07 |
ENST00000373418.3
|
PHC2
|
polyhomeotic homolog 2 (Drosophila) |
chr16_-_89724051 | 2.06 |
ENST00000550102.1
|
CHMP1A
|
charged multivesicular body protein 1A |
chr17_+_75137460 | 2.06 |
ENST00000587820.1
|
SEC14L1
|
SEC14-like 1 (S. cerevisiae) |
chr18_+_77160282 | 2.04 |
ENST00000318065.5
ENST00000545796.1 ENST00000592223.1 ENST00000329101.4 ENST00000586434.1 |
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
chr19_-_4723761 | 2.04 |
ENST00000597849.1
ENST00000598800.1 ENST00000602161.1 ENST00000597726.1 ENST00000601130.1 ENST00000262960.9 |
DPP9
|
dipeptidyl-peptidase 9 |
chr1_-_150947299 | 2.03 |
ENST00000361419.5
|
CERS2
|
ceramide synthase 2 |
chr1_+_206858328 | 2.03 |
ENST00000367103.3
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2 |
chr12_-_58131931 | 2.03 |
ENST00000547588.1
|
AGAP2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
chr3_-_113415441 | 2.03 |
ENST00000491165.1
ENST00000316407.4 |
KIAA2018
|
KIAA2018 |
chr12_-_54071181 | 2.01 |
ENST00000338662.5
|
ATP5G2
|
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9) |
chr5_-_179285785 | 2.01 |
ENST00000520698.1
ENST00000518235.1 ENST00000376931.2 ENST00000518219.1 ENST00000521333.1 ENST00000523084.1 |
C5orf45
|
chromosome 5 open reading frame 45 |
chr7_-_105925558 | 2.01 |
ENST00000222553.3
|
NAMPT
|
nicotinamide phosphoribosyltransferase |
chr7_-_150497406 | 2.00 |
ENST00000492607.1
ENST00000326442.5 ENST00000450753.2 |
TMEM176B
|
transmembrane protein 176B |
chr19_-_42759266 | 1.96 |
ENST00000594664.1
|
AC006486.9
|
Uncharacterized protein |
chr8_-_134584152 | 1.95 |
ENST00000521180.1
ENST00000517668.1 ENST00000319914.5 |
ST3GAL1
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
chr21_-_16437126 | 1.95 |
ENST00000318948.4
|
NRIP1
|
nuclear receptor interacting protein 1 |
chr16_+_21610797 | 1.93 |
ENST00000358154.3
|
METTL9
|
methyltransferase like 9 |
chr17_+_21187976 | 1.93 |
ENST00000342679.4
|
MAP2K3
|
mitogen-activated protein kinase kinase 3 |
chr11_+_118978045 | 1.93 |
ENST00000336702.3
|
C2CD2L
|
C2CD2-like |
chr5_-_180229833 | 1.93 |
ENST00000307826.4
|
MGAT1
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
chr1_-_33168336 | 1.92 |
ENST00000373484.3
|
SYNC
|
syncoilin, intermediate filament protein |
chr18_+_77155856 | 1.92 |
ENST00000253506.5
ENST00000591814.1 |
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
chr1_-_182361327 | 1.92 |
ENST00000331872.6
ENST00000311223.5 |
GLUL
|
glutamate-ammonia ligase |
chr1_+_154378049 | 1.92 |
ENST00000512471.1
|
IL6R
|
interleukin 6 receptor |
chr7_+_150497491 | 1.90 |
ENST00000484928.1
|
TMEM176A
|
transmembrane protein 176A |
chr1_+_17866290 | 1.90 |
ENST00000361221.3
ENST00000452522.1 ENST00000434513.1 |
ARHGEF10L
|
Rho guanine nucleotide exchange factor (GEF) 10-like |
chr22_-_37415475 | 1.89 |
ENST00000403892.3
ENST00000249042.3 ENST00000438203.1 |
TST
|
thiosulfate sulfurtransferase (rhodanese) |
chr7_-_100493744 | 1.89 |
ENST00000428317.1
ENST00000441605.1 |
ACHE
|
acetylcholinesterase (Yt blood group) |
chr6_-_160114260 | 1.89 |
ENST00000367054.2
ENST00000367055.4 ENST00000444946.2 ENST00000452684.2 |
SOD2
|
superoxide dismutase 2, mitochondrial |
chr12_+_68042517 | 1.88 |
ENST00000393555.3
|
DYRK2
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 |
chr2_+_238600933 | 1.88 |
ENST00000420665.1
ENST00000392000.4 |
LRRFIP1
|
leucine rich repeat (in FLII) interacting protein 1 |
chr19_-_30206128 | 1.87 |
ENST00000392276.1
ENST00000592153.1 ENST00000323670.9 |
C19orf12
|
chromosome 19 open reading frame 12 |
chrX_+_48455866 | 1.87 |
ENST00000376729.5
ENST00000218056.5 |
WDR13
|
WD repeat domain 13 |
chr7_-_105926058 | 1.86 |
ENST00000417537.1
|
NAMPT
|
nicotinamide phosphoribosyltransferase |
chr19_+_13056663 | 1.86 |
ENST00000541222.1
ENST00000316856.3 ENST00000586534.1 ENST00000592268.1 |
RAD23A
|
RAD23 homolog A (S. cerevisiae) |
chr4_-_1166623 | 1.86 |
ENST00000290902.5
|
SPON2
|
spondin 2, extracellular matrix protein |
chr16_+_87425914 | 1.86 |
ENST00000565788.1
|
MAP1LC3B
|
microtubule-associated protein 1 light chain 3 beta |
chr9_+_138392483 | 1.86 |
ENST00000241600.5
|
MRPS2
|
mitochondrial ribosomal protein S2 |
chr5_-_179233314 | 1.86 |
ENST00000523108.1
|
MGAT4B
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B |
chr9_-_139440314 | 1.85 |
ENST00000277541.6
|
NOTCH1
|
notch 1 |
chr15_-_64338521 | 1.84 |
ENST00000457488.1
ENST00000558069.1 |
DAPK2
|
death-associated protein kinase 2 |
chr17_+_73083816 | 1.83 |
ENST00000580123.1
ENST00000578847.1 |
SLC16A5
|
solute carrier family 16 (monocarboxylate transporter), member 5 |
chr16_+_29817399 | 1.83 |
ENST00000545521.1
|
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
chr3_-_24536453 | 1.83 |
ENST00000453729.2
ENST00000413780.1 |
THRB
|
thyroid hormone receptor, beta |
chr22_-_19419205 | 1.83 |
ENST00000340170.4
ENST00000263208.5 |
HIRA
|
histone cell cycle regulator |
chr1_+_16010779 | 1.80 |
ENST00000375799.3
ENST00000375793.2 |
PLEKHM2
|
pleckstrin homology domain containing, family M (with RUN domain) member 2 |
chrX_-_21676442 | 1.80 |
ENST00000379499.2
|
KLHL34
|
kelch-like family member 34 |
chr18_-_28681950 | 1.79 |
ENST00000251081.6
|
DSC2
|
desmocollin 2 |
chr17_-_73267304 | 1.79 |
ENST00000579297.1
ENST00000580571.1 |
MIF4GD
|
MIF4G domain containing |
chr12_+_122459757 | 1.78 |
ENST00000261822.4
|
BCL7A
|
B-cell CLL/lymphoma 7A |
chr17_+_78965624 | 1.77 |
ENST00000325167.5
|
CHMP6
|
charged multivesicular body protein 6 |
chr5_-_179285848 | 1.77 |
ENST00000403396.2
ENST00000292586.6 |
C5orf45
|
chromosome 5 open reading frame 45 |
chr1_+_203274639 | 1.77 |
ENST00000290551.4
|
BTG2
|
BTG family, member 2 |
chr20_+_35202909 | 1.76 |
ENST00000558530.1
ENST00000558028.1 ENST00000560025.1 |
TGIF2-C20orf24
TGIF2
|
TGIF2-C20orf24 readthrough TGFB-induced factor homeobox 2 |
chr5_-_179233934 | 1.76 |
ENST00000292591.7
|
MGAT4B
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B |
chr6_-_160114293 | 1.76 |
ENST00000337404.4
ENST00000538183.2 |
SOD2
|
superoxide dismutase 2, mitochondrial |
chr4_-_36245561 | 1.75 |
ENST00000506189.1
|
ARAP2
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
chr15_-_60884706 | 1.75 |
ENST00000449337.2
|
RORA
|
RAR-related orphan receptor A |
chr9_+_132815985 | 1.75 |
ENST00000372410.3
|
GPR107
|
G protein-coupled receptor 107 |
chr12_-_76478417 | 1.75 |
ENST00000552342.1
|
NAP1L1
|
nucleosome assembly protein 1-like 1 |
chr11_+_1968508 | 1.74 |
ENST00000397298.3
ENST00000381519.1 ENST00000397297.3 ENST00000381514.3 ENST00000397294.3 |
MRPL23
|
mitochondrial ribosomal protein L23 |
chr17_+_78234625 | 1.74 |
ENST00000508628.2
ENST00000582970.1 ENST00000456466.1 ENST00000319921.4 |
RNF213
|
ring finger protein 213 |
chr2_-_25564750 | 1.74 |
ENST00000321117.5
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha |
chr18_-_60987220 | 1.74 |
ENST00000398117.1
|
BCL2
|
B-cell CLL/lymphoma 2 |
chr20_-_39317868 | 1.73 |
ENST00000373313.2
|
MAFB
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B |
chr8_-_131028641 | 1.73 |
ENST00000523509.1
|
FAM49B
|
family with sequence similarity 49, member B |
chr14_-_51297197 | 1.73 |
ENST00000382043.4
|
NIN
|
ninein (GSK3B interacting protein) |
chr13_-_114898016 | 1.73 |
ENST00000542651.1
ENST00000334062.7 |
RASA3
|
RAS p21 protein activator 3 |
chr18_-_74844713 | 1.73 |
ENST00000397860.3
|
MBP
|
myelin basic protein |
chr3_-_5229982 | 1.72 |
ENST00000600805.1
|
AC026202.1
|
Uncharacterized protein |
chr20_-_50179368 | 1.72 |
ENST00000609943.1
ENST00000609507.1 |
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
chr6_-_91006627 | 1.71 |
ENST00000537989.1
|
BACH2
|
BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
chr6_+_160390102 | 1.71 |
ENST00000356956.1
|
IGF2R
|
insulin-like growth factor 2 receptor |
chr8_+_37553261 | 1.71 |
ENST00000331569.4
|
ZNF703
|
zinc finger protein 703 |
chr11_-_130184470 | 1.71 |
ENST00000357899.4
ENST00000397753.1 |
ZBTB44
|
zinc finger and BTB domain containing 44 |
chr17_-_78194716 | 1.71 |
ENST00000576707.1
|
SGSH
|
N-sulfoglucosamine sulfohydrolase |
chr3_+_45635661 | 1.71 |
ENST00000440097.1
|
LIMD1
|
LIM domains containing 1 |
chr1_+_27022839 | 1.70 |
ENST00000457599.2
|
ARID1A
|
AT rich interactive domain 1A (SWI-like) |
chr1_+_1447517 | 1.70 |
ENST00000378756.3
ENST00000378755.5 |
ATAD3A
|
ATPase family, AAA domain containing 3A |
chr10_+_11060004 | 1.70 |
ENST00000542579.1
ENST00000399850.3 ENST00000417956.2 |
CELF2
|
CUGBP, Elav-like family member 2 |
chr1_-_42800614 | 1.69 |
ENST00000372572.1
|
FOXJ3
|
forkhead box J3 |
chr20_+_34894247 | 1.69 |
ENST00000373913.3
|
DLGAP4
|
discs, large (Drosophila) homolog-associated protein 4 |
chr2_-_225907150 | 1.69 |
ENST00000258390.7
|
DOCK10
|
dedicator of cytokinesis 10 |
chr3_+_16926441 | 1.69 |
ENST00000418129.2
ENST00000396755.2 |
PLCL2
|
phospholipase C-like 2 |
chr8_-_28243590 | 1.69 |
ENST00000523095.1
ENST00000522795.1 |
ZNF395
|
zinc finger protein 395 |
chr5_-_14871866 | 1.69 |
ENST00000284268.6
|
ANKH
|
ANKH inorganic pyrophosphate transport regulator |
chr6_-_146056341 | 1.69 |
ENST00000435470.1
|
EPM2A
|
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) |
chr20_+_13202418 | 1.68 |
ENST00000262487.4
|
ISM1
|
isthmin 1, angiogenesis inhibitor |
chr10_-_126432821 | 1.67 |
ENST00000280780.6
|
FAM53B
|
family with sequence similarity 53, member B |
chr13_+_28712614 | 1.67 |
ENST00000380958.3
|
PAN3
|
PAN3 poly(A) specific ribonuclease subunit homolog (S. cerevisiae) |
chr1_+_206858232 | 1.66 |
ENST00000294981.4
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2 |
chr14_+_95982451 | 1.66 |
ENST00000554161.1
|
RP11-1070N10.3
|
Uncharacterized protein |
chr11_+_64073022 | 1.65 |
ENST00000406310.1
ENST00000000442.6 ENST00000539594.1 |
ESRRA
|
estrogen-related receptor alpha |
chr14_+_90864504 | 1.65 |
ENST00000544280.2
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta) |
chr3_+_98451532 | 1.65 |
ENST00000486334.2
ENST00000394162.1 |
ST3GAL6
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 6 |
chr5_+_179233376 | 1.65 |
ENST00000376929.3
ENST00000514093.1 |
SQSTM1
|
sequestosome 1 |
chr14_-_65346555 | 1.64 |
ENST00000542895.1
ENST00000556626.1 |
SPTB
|
spectrin, beta, erythrocytic |
chr11_-_67169265 | 1.64 |
ENST00000358239.4
ENST00000376745.4 |
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme |
chr16_+_68279256 | 1.63 |
ENST00000564827.2
ENST00000566188.1 ENST00000444212.2 ENST00000568082.1 |
PLA2G15
|
phospholipase A2, group XV |
chr7_-_134855517 | 1.62 |
ENST00000430372.1
|
C7orf49
|
chromosome 7 open reading frame 49 |
chr1_-_19229014 | 1.62 |
ENST00000538839.1
ENST00000290597.5 |
ALDH4A1
|
aldehyde dehydrogenase 4 family, member A1 |
chr17_+_36861735 | 1.62 |
ENST00000378137.5
ENST00000325718.7 |
MLLT6
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 |
chr21_-_16437255 | 1.62 |
ENST00000400199.1
ENST00000400202.1 |
NRIP1
|
nuclear receptor interacting protein 1 |
chr10_+_99079008 | 1.62 |
ENST00000371021.3
|
FRAT1
|
frequently rearranged in advanced T-cell lymphomas |
chr16_+_89160269 | 1.61 |
ENST00000540697.1
ENST00000406948.3 ENST00000378345.4 ENST00000541755.2 |
ACSF3
|
acyl-CoA synthetase family member 3 |
chr1_-_226070016 | 1.61 |
ENST00000366835.3
|
TMEM63A
|
transmembrane protein 63A |
chr6_-_24911195 | 1.61 |
ENST00000259698.4
|
FAM65B
|
family with sequence similarity 65, member B |
chr16_-_11680759 | 1.60 |
ENST00000571459.1
ENST00000570798.1 ENST00000572255.1 ENST00000574763.1 ENST00000574703.1 ENST00000571277.1 ENST00000381810.3 |
LITAF
|
lipopolysaccharide-induced TNF factor |
chrX_-_153714917 | 1.60 |
ENST00000369653.4
|
UBL4A
|
ubiquitin-like 4A |
chr17_-_66287257 | 1.60 |
ENST00000327268.4
|
SLC16A6
|
solute carrier family 16, member 6 |
chr10_-_6622258 | 1.59 |
ENST00000263125.5
|
PRKCQ
|
protein kinase C, theta |
chr17_-_4890919 | 1.59 |
ENST00000572543.1
ENST00000381311.5 ENST00000348066.3 ENST00000358183.4 |
CAMTA2
|
calmodulin binding transcription activator 2 |
chr9_-_139581875 | 1.59 |
ENST00000371696.2
|
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 |
chr1_+_150522222 | 1.59 |
ENST00000369039.5
|
ADAMTSL4
|
ADAMTS-like 4 |
chrX_+_154611749 | 1.59 |
ENST00000369505.3
|
F8A2
|
coagulation factor VIII-associated 2 |
chr5_-_133340326 | 1.59 |
ENST00000425992.1
ENST00000395044.3 ENST00000395047.2 |
VDAC1
|
voltage-dependent anion channel 1 |
chr4_+_1003742 | 1.59 |
ENST00000398484.2
|
FGFRL1
|
fibroblast growth factor receptor-like 1 |
chr9_-_138987115 | 1.58 |
ENST00000277554.2
|
NACC2
|
NACC family member 2, BEN and BTB (POZ) domain containing |
chr7_-_149470540 | 1.58 |
ENST00000302017.3
|
ZNF467
|
zinc finger protein 467 |
chr12_-_122907091 | 1.58 |
ENST00000358808.2
ENST00000361654.4 ENST00000539080.1 ENST00000537178.1 |
CLIP1
|
CAP-GLY domain containing linker protein 1 |
chr2_+_131113609 | 1.57 |
ENST00000347849.3
|
PTPN18
|
protein tyrosine phosphatase, non-receptor type 18 (brain-derived) |
chr4_+_2819883 | 1.57 |
ENST00000511747.1
ENST00000503393.2 |
SH3BP2
|
SH3-domain binding protein 2 |
chr16_+_66638685 | 1.57 |
ENST00000565003.1
|
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
chr13_-_53024725 | 1.57 |
ENST00000378060.4
|
VPS36
|
vacuolar protein sorting 36 homolog (S. cerevisiae) |
chr19_+_58919992 | 1.57 |
ENST00000306910.4
ENST00000598901.1 ENST00000593920.1 ENST00000596281.1 |
ZNF584
|
zinc finger protein 584 |
chr16_-_85045069 | 1.56 |
ENST00000564466.1
|
ZDHHC7
|
zinc finger, DHHC-type containing 7 |
chr8_-_33424636 | 1.56 |
ENST00000256257.1
|
RNF122
|
ring finger protein 122 |
chr5_-_133340682 | 1.56 |
ENST00000265333.3
|
VDAC1
|
voltage-dependent anion channel 1 |
chr12_-_76477707 | 1.56 |
ENST00000551992.1
|
NAP1L1
|
nucleosome assembly protein 1-like 1 |
chr19_-_58919815 | 1.56 |
ENST00000597980.1
|
CTD-2619J13.14
|
CTD-2619J13.14 |
chr19_-_3061397 | 1.56 |
ENST00000586839.1
|
AES
|
amino-terminal enhancer of split |
chr7_-_100487280 | 1.55 |
ENST00000388761.2
|
UFSP1
|
UFM1-specific peptidase 1 (non-functional) |
chr18_+_11981014 | 1.55 |
ENST00000589238.1
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
chr6_-_134495992 | 1.55 |
ENST00000475719.2
ENST00000367857.5 ENST00000237305.7 |
SGK1
|
serum/glucocorticoid regulated kinase 1 |
chr8_+_38758737 | 1.54 |
ENST00000521746.1
ENST00000420274.1 |
PLEKHA2
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 2 |
chr7_+_150065879 | 1.54 |
ENST00000397281.2
ENST00000444957.1 ENST00000466559.1 ENST00000489432.2 ENST00000475514.1 ENST00000482680.1 ENST00000488943.1 ENST00000518514.1 ENST00000478789.1 |
REPIN1
ZNF775
|
replication initiator 1 zinc finger protein 775 |
chr16_+_68279207 | 1.54 |
ENST00000413021.2
ENST00000565744.1 ENST00000219345.5 |
PLA2G15
|
phospholipase A2, group XV |
chr11_+_45825896 | 1.54 |
ENST00000314134.3
|
SLC35C1
|
solute carrier family 35 (GDP-fucose transporter), member C1 |
chr1_+_207226574 | 1.53 |
ENST00000367080.3
ENST00000367079.2 |
PFKFB2
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 |
chr6_-_4135693 | 1.53 |
ENST00000495548.1
ENST00000380125.2 ENST00000465828.1 |
ECI2
|
enoyl-CoA delta isomerase 2 |
chr17_-_1532106 | 1.53 |
ENST00000301335.5
ENST00000382147.4 |
SLC43A2
|
solute carrier family 43 (amino acid system L transporter), member 2 |
chr1_-_156721389 | 1.53 |
ENST00000537739.1
|
HDGF
|
hepatoma-derived growth factor |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 8.2 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
1.7 | 5.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
1.3 | 3.8 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
1.2 | 3.7 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
1.2 | 6.1 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
1.2 | 3.6 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
1.2 | 4.7 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
1.1 | 3.4 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
1.1 | 4.2 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
1.0 | 3.9 | GO:0003169 | coronary vein morphogenesis(GO:0003169) |
1.0 | 3.8 | GO:1905045 | Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
1.0 | 3.8 | GO:0002384 | hepatic immune response(GO:0002384) |
0.9 | 2.8 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
0.9 | 2.7 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
0.9 | 4.5 | GO:2000567 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.9 | 3.5 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.9 | 2.6 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.9 | 3.5 | GO:0097045 | phosphatidylserine exposure on blood platelet(GO:0097045) |
0.8 | 2.5 | GO:0046730 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
0.8 | 1.7 | GO:0016049 | cell growth(GO:0016049) |
0.8 | 3.4 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.8 | 2.5 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
0.8 | 3.3 | GO:0032848 | negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
0.8 | 5.6 | GO:1903788 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
0.8 | 0.8 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.8 | 2.4 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
0.8 | 3.2 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.8 | 7.0 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.8 | 0.8 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.8 | 2.3 | GO:0072684 | mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
0.8 | 3.8 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.8 | 4.5 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.8 | 2.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.7 | 3.0 | GO:2000569 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
0.7 | 3.0 | GO:1904481 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
0.7 | 1.5 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.7 | 5.1 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.7 | 3.6 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.7 | 4.4 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
0.7 | 0.7 | GO:0090343 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
0.7 | 0.7 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.7 | 5.7 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.7 | 2.8 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.7 | 5.0 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.7 | 3.5 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
0.7 | 2.8 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
0.7 | 2.1 | GO:0046041 | ITP metabolic process(GO:0046041) |
0.7 | 2.7 | GO:0090410 | malonate catabolic process(GO:0090410) |
0.7 | 4.6 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.7 | 2.0 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.6 | 1.9 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
0.6 | 2.5 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.6 | 1.9 | GO:0070668 | regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.6 | 1.9 | GO:0007388 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
0.6 | 1.9 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.6 | 0.6 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.6 | 1.9 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
0.6 | 1.9 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.6 | 0.6 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.6 | 5.6 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.6 | 0.6 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.6 | 3.0 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.6 | 4.2 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
0.6 | 1.8 | GO:0071338 | submandibular salivary gland formation(GO:0060661) hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
0.6 | 2.3 | GO:0006850 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
0.6 | 1.7 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.6 | 2.9 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.6 | 0.6 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.6 | 1.7 | GO:0021571 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.6 | 1.7 | GO:0021793 | chemorepulsion of branchiomotor axon(GO:0021793) |
0.6 | 2.9 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.6 | 4.0 | GO:0046016 | positive regulation of transcription by glucose(GO:0046016) |
0.6 | 3.9 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.6 | 3.4 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.6 | 4.4 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
0.6 | 1.7 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.6 | 5.5 | GO:0046898 | response to cycloheximide(GO:0046898) |
0.5 | 8.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.5 | 2.7 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
0.5 | 2.2 | GO:0032902 | nerve growth factor production(GO:0032902) |
0.5 | 2.7 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.5 | 2.1 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
0.5 | 8.0 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.5 | 5.9 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.5 | 8.0 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.5 | 1.6 | GO:1903515 | calcium ion transport from cytosol to endoplasmic reticulum(GO:1903515) |
0.5 | 1.6 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
0.5 | 4.2 | GO:0007296 | vitellogenesis(GO:0007296) |
0.5 | 2.1 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.5 | 3.1 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
0.5 | 2.1 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.5 | 3.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.5 | 2.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.5 | 0.5 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
0.5 | 3.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.5 | 3.5 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.5 | 2.0 | GO:0002432 | granuloma formation(GO:0002432) |
0.5 | 2.0 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.5 | 1.5 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.5 | 4.0 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.5 | 2.0 | GO:1904978 | regulation of endosome organization(GO:1904978) |
0.5 | 0.5 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.5 | 1.5 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.5 | 1.0 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.5 | 1.0 | GO:1902823 | negative regulation of late endosome to lysosome transport(GO:1902823) |
0.5 | 1.0 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
0.5 | 1.5 | GO:0071030 | nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
0.5 | 1.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.5 | 0.5 | GO:2001076 | thorax and anterior abdomen determination(GO:0007356) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
0.5 | 7.3 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.5 | 1.9 | GO:0051413 | response to cortisone(GO:0051413) |
0.5 | 1.0 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
0.5 | 2.4 | GO:0008050 | female courtship behavior(GO:0008050) |
0.5 | 4.3 | GO:0046836 | glycolipid transport(GO:0046836) |
0.5 | 2.4 | GO:0006045 | N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
0.5 | 1.0 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.5 | 2.4 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.5 | 5.2 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.5 | 1.9 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.5 | 1.4 | GO:0042040 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
0.5 | 1.4 | GO:0033341 | regulation of collagen binding(GO:0033341) |
0.5 | 1.4 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
0.5 | 2.3 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
0.5 | 2.8 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.5 | 2.3 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.5 | 0.9 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.5 | 3.2 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
0.5 | 1.8 | GO:0006218 | uridine catabolic process(GO:0006218) |
0.5 | 1.8 | GO:0050992 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
0.5 | 0.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.5 | 2.3 | GO:0032796 | uropod organization(GO:0032796) |
0.5 | 1.8 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
0.5 | 2.3 | GO:0044501 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.5 | 0.5 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.5 | 2.7 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.5 | 1.4 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
0.5 | 1.4 | GO:0060691 | epithelial cell differentiation involved in salivary gland development(GO:0060690) epithelial cell maturation involved in salivary gland development(GO:0060691) regulation of plasma cell differentiation(GO:1900098) positive regulation of plasma cell differentiation(GO:1900100) positive regulation of lactation(GO:1903489) |
0.5 | 1.8 | GO:0021897 | forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
0.4 | 2.7 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.4 | 0.4 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
0.4 | 1.3 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.4 | 3.1 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.4 | 5.8 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.4 | 4.0 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.4 | 2.2 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.4 | 4.4 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.4 | 2.2 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
0.4 | 2.6 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
0.4 | 0.4 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.4 | 1.3 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
0.4 | 2.2 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
0.4 | 0.4 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.4 | 0.4 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
0.4 | 1.3 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.4 | 1.3 | GO:0014040 | acetaldehyde metabolic process(GO:0006117) positive regulation of Schwann cell differentiation(GO:0014040) |
0.4 | 1.3 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.4 | 0.4 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.4 | 6.7 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.4 | 1.3 | GO:0043602 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) |
0.4 | 1.2 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
0.4 | 1.2 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
0.4 | 2.5 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.4 | 1.2 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
0.4 | 1.2 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.4 | 2.9 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
0.4 | 3.7 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.4 | 0.8 | GO:0072434 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
0.4 | 2.5 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.4 | 2.1 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.4 | 0.4 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.4 | 0.8 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.4 | 1.6 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.4 | 1.2 | GO:0046022 | positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.4 | 0.8 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.4 | 0.4 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.4 | 1.2 | GO:0036491 | regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) |
0.4 | 0.4 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.4 | 0.4 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
0.4 | 0.8 | GO:0071484 | cellular response to light intensity(GO:0071484) |
0.4 | 1.2 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.4 | 3.6 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.4 | 1.6 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.4 | 0.8 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
0.4 | 0.4 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.4 | 1.6 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.4 | 1.6 | GO:2000176 | regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
0.4 | 3.6 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.4 | 6.3 | GO:0044351 | macropinocytosis(GO:0044351) |
0.4 | 1.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.4 | 0.4 | GO:0042823 | pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
0.4 | 2.0 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.4 | 3.1 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.4 | 0.8 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.4 | 2.3 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.4 | 1.6 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.4 | 2.7 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.4 | 0.4 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
0.4 | 0.4 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.4 | 1.2 | GO:0044209 | AMP salvage(GO:0044209) |
0.4 | 0.8 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
0.4 | 1.2 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
0.4 | 0.4 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.4 | 1.5 | GO:0019521 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
0.4 | 0.4 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.4 | 1.5 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
0.4 | 2.3 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
0.4 | 1.9 | GO:1903615 | regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
0.4 | 1.1 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.4 | 1.9 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.4 | 1.1 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.4 | 1.1 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.4 | 1.5 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.4 | 1.9 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.4 | 3.4 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.4 | 1.5 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.4 | 0.4 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.4 | 1.9 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.4 | 4.9 | GO:0060022 | hard palate development(GO:0060022) |
0.4 | 1.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.4 | 0.7 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.4 | 14.8 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.4 | 1.1 | GO:0033128 | negative regulation of histone phosphorylation(GO:0033128) |
0.4 | 1.1 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.4 | 1.8 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.4 | 1.1 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.4 | 3.3 | GO:0010269 | response to selenium ion(GO:0010269) |
0.4 | 1.1 | GO:1901526 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.4 | 0.7 | GO:0097466 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.4 | 0.7 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
0.4 | 6.6 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
0.4 | 1.1 | GO:0050720 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) interleukin-1 beta biosynthetic process(GO:0050720) |
0.4 | 4.0 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.4 | 1.5 | GO:0035668 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
0.4 | 1.1 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.4 | 1.1 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
0.4 | 0.4 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.4 | 1.8 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.4 | 1.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.4 | 0.7 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.4 | 3.2 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.4 | 0.4 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.4 | 5.3 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.4 | 2.1 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.4 | 2.5 | GO:0070417 | cellular response to cold(GO:0070417) |
0.4 | 1.1 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.4 | 3.2 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.4 | 0.4 | GO:1904951 | positive regulation of establishment of protein localization(GO:1904951) |
0.4 | 1.1 | GO:0032618 | interleukin-15 production(GO:0032618) |
0.4 | 0.7 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.3 | 0.3 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.3 | 2.4 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.3 | 7.0 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.3 | 0.7 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
0.3 | 1.0 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.3 | 1.4 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.3 | 0.7 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.3 | 1.0 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.3 | 1.0 | GO:1904685 | positive regulation of metalloendopeptidase activity(GO:1904685) |
0.3 | 1.4 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.3 | 4.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.3 | 5.8 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.3 | 1.4 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
0.3 | 4.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.3 | 2.4 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.3 | 2.4 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.3 | 1.4 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
0.3 | 0.7 | GO:0070781 | response to biotin(GO:0070781) |
0.3 | 0.3 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
0.3 | 6.7 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.3 | 2.0 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.3 | 0.3 | GO:0018283 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
0.3 | 3.0 | GO:0006477 | protein sulfation(GO:0006477) |
0.3 | 1.3 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.3 | 0.3 | GO:1900223 | positive regulation of beta-amyloid clearance(GO:1900223) |
0.3 | 2.0 | GO:2001153 | negative regulation of glycogen (starch) synthase activity(GO:2000466) regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
0.3 | 0.7 | GO:0003192 | mitral valve formation(GO:0003192) |
0.3 | 0.3 | GO:0035148 | tube formation(GO:0035148) |
0.3 | 0.7 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.3 | 1.0 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.3 | 0.3 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.3 | 0.3 | GO:0060157 | urinary bladder development(GO:0060157) |
0.3 | 0.7 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.3 | 4.5 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.3 | 0.6 | GO:1901656 | glycoside transport(GO:1901656) |
0.3 | 1.6 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.3 | 1.0 | GO:0042938 | dipeptide transport(GO:0042938) |
0.3 | 1.3 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.3 | 0.6 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.3 | 0.3 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
0.3 | 2.6 | GO:0046618 | drug export(GO:0046618) |
0.3 | 1.6 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.3 | 1.0 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
0.3 | 5.1 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.3 | 5.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.3 | 0.9 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.3 | 3.5 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.3 | 1.3 | GO:0071233 | cellular response to leucine(GO:0071233) |
0.3 | 1.3 | GO:0097202 | activation of cysteine-type endopeptidase activity(GO:0097202) |
0.3 | 1.3 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
0.3 | 0.9 | GO:0009405 | pathogenesis(GO:0009405) |
0.3 | 0.3 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.3 | 6.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.3 | 0.9 | GO:1904640 | response to methionine(GO:1904640) |
0.3 | 1.6 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.3 | 0.6 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.3 | 0.3 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.3 | 0.3 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.3 | 0.6 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
0.3 | 2.5 | GO:0072642 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
0.3 | 1.2 | GO:1903381 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
0.3 | 1.2 | GO:1990535 | neuron projection maintenance(GO:1990535) |
0.3 | 1.5 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) |
0.3 | 0.9 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.3 | 0.9 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
0.3 | 2.7 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.3 | 2.1 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.3 | 0.9 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
0.3 | 0.9 | GO:0003249 | cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) cell proliferation involved in heart valve development(GO:2000793) |
0.3 | 5.4 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.3 | 3.9 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 0.3 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
0.3 | 2.4 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.3 | 3.9 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.3 | 0.3 | GO:0061009 | common bile duct development(GO:0061009) |
0.3 | 1.8 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
0.3 | 1.8 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.3 | 1.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 1.2 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.3 | 1.5 | GO:0046368 | GDP-L-fucose biosynthetic process(GO:0042350) GDP-L-fucose metabolic process(GO:0046368) |
0.3 | 0.6 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.3 | 1.2 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.3 | 0.9 | GO:0060730 | regulation of intestinal epithelial structure maintenance(GO:0060730) |
0.3 | 0.6 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.3 | 2.4 | GO:0045007 | depurination(GO:0045007) |
0.3 | 3.0 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.3 | 1.8 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 0.3 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
0.3 | 2.6 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
0.3 | 0.6 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
0.3 | 0.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.3 | 1.7 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.3 | 2.0 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
0.3 | 2.0 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.3 | 2.9 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.3 | 0.6 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.3 | 1.7 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.3 | 0.9 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.3 | 2.0 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.3 | 0.6 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.3 | 1.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.3 | 0.9 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.3 | 2.0 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.3 | 1.1 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.3 | 0.6 | GO:0000077 | DNA damage checkpoint(GO:0000077) |
0.3 | 1.1 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
0.3 | 8.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.3 | 0.3 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
0.3 | 1.4 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.3 | 1.4 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.3 | 1.4 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.3 | 0.3 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.3 | 3.9 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.3 | 0.8 | GO:0071529 | cementum mineralization(GO:0071529) |
0.3 | 7.7 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.3 | 4.1 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.3 | 4.1 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.3 | 0.8 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.3 | 1.1 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.3 | 1.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.3 | 0.8 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
0.3 | 1.4 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.3 | 39.5 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.3 | 0.3 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.3 | 1.1 | GO:0045208 | MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
0.3 | 0.5 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.3 | 1.3 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.3 | 1.3 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.3 | 0.5 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
0.3 | 0.3 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.3 | 1.1 | GO:0046643 | regulation of gamma-delta T cell activation(GO:0046643) |
0.3 | 0.5 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.3 | 1.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.3 | 1.6 | GO:0043366 | beta selection(GO:0043366) |
0.3 | 5.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.3 | 2.7 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.3 | 1.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.3 | 1.1 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.3 | 4.8 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.3 | 0.8 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.3 | 2.1 | GO:1904386 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
0.3 | 0.3 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.3 | 0.8 | GO:0061485 | memory T cell proliferation(GO:0061485) |
0.3 | 0.5 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.3 | 0.8 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.3 | 0.3 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.3 | 3.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.3 | 1.0 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
0.3 | 1.0 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.3 | 0.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.3 | 2.3 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.3 | 5.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.3 | 0.8 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.3 | 4.6 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.3 | 3.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.3 | 3.9 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.3 | 0.8 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.3 | 0.3 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.3 | 0.8 | GO:0032824 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) positive regulation of cytolysis in other organism(GO:0051714) |
0.3 | 1.0 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.3 | 5.3 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.3 | 2.3 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.3 | 1.5 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.3 | 0.8 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.3 | 0.5 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.3 | 3.3 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.3 | 0.5 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.3 | 0.8 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.2 | 2.0 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.2 | 0.5 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 1.5 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.2 | 1.2 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.2 | 2.0 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.2 | 3.0 | GO:0008213 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.2 | 0.7 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
0.2 | 1.0 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.2 | 2.0 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.2 | 1.0 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.2 | 2.9 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.2 | 2.2 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.2 | 0.5 | GO:0035419 | activation of MAPK activity involved in innate immune response(GO:0035419) |
0.2 | 3.9 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.2 | 0.7 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.2 | 1.7 | GO:0071964 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
0.2 | 0.5 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.2 | 1.7 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
0.2 | 0.5 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.2 | 0.5 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.2 | 1.7 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.2 | 0.5 | GO:0090135 | actin filament branching(GO:0090135) |
0.2 | 0.5 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.2 | 0.5 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.2 | 1.4 | GO:1902164 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.2 | 0.2 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
0.2 | 2.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.2 | 3.1 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
0.2 | 1.9 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 | 3.1 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.2 | 0.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.2 | 1.7 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.2 | 1.0 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.2 | 1.2 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.2 | 1.2 | GO:1905007 | positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905007) |
0.2 | 0.7 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.2 | 1.0 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
0.2 | 1.2 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.2 | 2.4 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.2 | 1.2 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.2 | 0.2 | GO:0000303 | response to superoxide(GO:0000303) |
0.2 | 0.9 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
0.2 | 0.2 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) |
0.2 | 1.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 0.5 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
0.2 | 4.7 | GO:0000338 | protein deneddylation(GO:0000338) |
0.2 | 1.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.2 | 0.7 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.2 | 0.7 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.2 | 0.2 | GO:0060038 | cardiac muscle cell proliferation(GO:0060038) heart growth(GO:0060419) |
0.2 | 0.5 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.2 | 2.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.2 | 0.9 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 0.7 | GO:0006043 | glucosamine catabolic process(GO:0006043) |
0.2 | 2.8 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
0.2 | 1.6 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.2 | 1.2 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.2 | 1.9 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.2 | 3.2 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.2 | 1.6 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.2 | 0.2 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.2 | 7.1 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.2 | 1.8 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.2 | 0.5 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.2 | 3.0 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.2 | 0.5 | GO:0061289 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.2 | 0.7 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.2 | 4.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.2 | 1.8 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.2 | 5.9 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.2 | 0.7 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.2 | 0.5 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.2 | 1.4 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
0.2 | 5.2 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
0.2 | 6.1 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.2 | 0.7 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.2 | 0.5 | GO:2001178 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
0.2 | 1.1 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.2 | 0.7 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.2 | 2.9 | GO:0051198 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.2 | 2.0 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 3.6 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.2 | 5.4 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.2 | 0.7 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
0.2 | 6.7 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.2 | 2.5 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 0.4 | GO:0006788 | heme oxidation(GO:0006788) |
0.2 | 0.9 | GO:0061582 | intestinal epithelial cell migration(GO:0061582) |
0.2 | 0.4 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.2 | 5.3 | GO:0036508 | protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) |
0.2 | 2.2 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.2 | 2.2 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.2 | 0.9 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.2 | 1.6 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.2 | 1.3 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 1.1 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.2 | 2.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 2.0 | GO:1901563 | response to camptothecin(GO:1901563) |
0.2 | 2.9 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 0.2 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.2 | 0.7 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.2 | 0.7 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.2 | 0.7 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
0.2 | 0.9 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.2 | 0.4 | GO:0033029 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
0.2 | 0.4 | GO:0007619 | courtship behavior(GO:0007619) |
0.2 | 0.9 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.2 | 1.1 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.2 | 1.7 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.2 | 0.4 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
0.2 | 1.3 | GO:0061187 | regulation of chromatin silencing at rDNA(GO:0061187) |
0.2 | 5.9 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.2 | 8.1 | GO:0006101 | citrate metabolic process(GO:0006101) |
0.2 | 0.2 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.2 | 2.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 2.0 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.2 | 0.2 | GO:2000197 | regulation of ribonucleoprotein complex localization(GO:2000197) |
0.2 | 0.9 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.2 | 0.6 | GO:1903410 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
0.2 | 0.9 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.2 | 3.0 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.2 | 0.9 |